August J. Troendle - 06 Mar 2025 Form 4 Insider Report for Medpace Holdings, Inc. (MEDP)

Role: CEO, Director, 10%+ Owner
Signature: /s/ Stephen P. Ewald, Attorney-in-Fact for August J. Troendle
Issuer symbol: MEDP
Transactions as of: 06 Mar 2025
Net transactions value: +$24,458,835
Form type: 4
Filing time: 10 Mar 2025, 17:47:50 UTC
Previous filing: 07 Aug 2024
Next filing: 29 Jul 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MEDP	Common Stock	Options Exercise	$2,048,207	+37,417	+5.7%	$54.74	692,073	07 Mar 2025	Direct
transaction	MEDP	Common Stock	Options Exercise	$13,261,402	+234,259	+34%	$56.61	926,332	07 Mar 2025	Direct
transaction	MEDP	Common Stock	Options Exercise	$9,149,226	+84,770	+9.2%	$107.93	1,011,102	07 Mar 2025	Direct
holding	MEDP	Common Stock						4,733,019	06 Mar 2025	By Medpace Investors, LLC	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MEDP	Employee Stock Option (Right to Buy)	Award	$0	+73,443		$0.000000	73,443	06 Mar 2025	Common Stock	73,443	$325.73	Direct	F2
transaction	MEDP	Employee Stock Option (Right to Buy)	Options Exercise	$0	-37,417	-100%	$0.000000	0	07 Mar 2025	Common Stock	37,417	$54.74	Direct
transaction	MEDP	Employee Stock Option (Right to Buy)	Options Exercise	$0	-234,259	-100%	$0.000000	0	07 Mar 2025	Common Stock	234,259	$56.61	Direct
transaction	MEDP	Employee Stock Option (Right to Buy)	Options Exercise	$0	-84,770	-100%	$0.000000	0	07 Mar 2025	Common Stock	84,770	$107.93	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
F2	The option vests immediately upon issuance.

Content

The Reporting Person is the sole manager and controlling unit holder of Medpace Investors, LLC ("MPI") and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

The option vests immediately upon issuance.